Suk S De Ravin
National Institute of Allergy and Infectious Diseases (NIAID)
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
8
all conditions, ClinicalTrials.gov
NIH grants tied to them
4
NIH RePORTER
Trial papers
0
PubMed author-name match
Trials
Studies that name Suk S De Ravin as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:39 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT07775313 · Base-Edited Hematopoietic Stem/Progenitor Cell Gene Therapy for Treatment of CXCR4-WHIMNational Institute of Allergy and Infectious Diseases (NIAID) · enrolling by invitation · WHIM, Warts, Hypogammaglobulinemia · principal investigator
- Ph1/Ph2NCT06959771 · Base Editing Hematopoietic Stem Cell and T Cell Gene Therapy for CD40L-HyperIgM Syndrome: Single Patient StudyNational Institute of Allergy and Infectious Diseases (NIAID) · recruiting · CD40L-HyperIgM Syndrome · principal investigator
- Ph1/Ph2NCT06851767 · Base-Edited Hematopoietic Stem/Progenitor Cell X-Linked Severe Combined Immunodeficiency Gene TherapyNational Institute of Allergy and Infectious Diseases (NIAID) · enrolling by invitation · X-linked Severe Combined Immunodeficiency, X-SCID, XSCID · principal investigator
- Ph1/Ph2NCT06325709 · Base Editing for Mutation Repair in Hematopoietic Stem & Progenitor Cells for X-Linked Chronic Granulomatous DiseaseNational Institute of Allergy and Infectious Diseases (NIAID) · recruiting · Chronic Granulomatous Disease (CGD), X-Linked Chronic Granulomatous Disease · principal investigator
- Ph1NCT05189925 · NADPH Oxidase Correction in mRNA-transfected Granulocyte-enriched Cells in Chronic Granulomatous Disease (CGD)National Institute of Allergy and Infectious Diseases (NIAID) · recruiting · Chronic Granulomatous Disease, Infection · principal investigator
- Ph1/Ph2NCT01306019 · Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)National Institute of Allergy and Infectious Diseases (NIAID) · recruiting · X-linked Severe Combined Immunodeficiency (XSCID) · principal investigator
- Ph1/Ph2NCT00490100 · Treatment for Growth Failure in Patients With X-Linked Severe Combined Immunodeficiency: Phase 2 Study of Insulin-Like Growth Factor-1National Institute of Allergy and Infectious Diseases (NIAID) · terminated · Growth Failure, X-linked Severe Combined Immunodeficiency (XSCID), Growth Hormone Resistence · principal investigator
- Ph1/Ph2NCT00325078 · Infliximab to Treat Crohn'S-like Inflammatory Bowel Disease in Chronic Granulomatous DiseaseNational Institute of Allergy and Infectious Diseases (NIAID) · terminated · Chronic Granulomatous Disease, Crohn'S-like IBD, Inflammatory Bowel Disease (IBD) · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:39 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Development and Clinical Application of Gene and Cell therapies for Patients with Immune DeficienciesZIAAI000645 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · fiscal years 2009 to 2025 · $576,014 awarded in 2025Same name and institution; not confirmed by an ID
- Gene Therapy Clinical Trials for X-linked Severe Combined ImmunodeficiencyZIAAI000992 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · fiscal years 2009 to 2019 · $361,831 awarded in 2019Same name and institution; not confirmed by an ID
- Clinical Diagnostic Studies and Treatment of Patients with Immune DeficienciesZ01AI000645 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · fiscal years 2008 · $387,461 awarded in 2008Same name and institution; not confirmed by an ID
- Gene Therapy Clinical Trials for X-linked Severe Combined ImmunodeficiencyZ01AI000992 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · fiscal years 2008 · $193,731 awarded in 2008Same name and institution; not confirmed by an ID
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.